Switching from aflibercept to brolucizumab for the treatment of refractory neovascular age-related macular degeneration

Hikaru Ota, Jun Takeuchi, Yuyako Nakano, Etsuyo Horiguchi, Yosuke Taki, Yasuki Ito, Hiroko Terasaki, Koji M. Nishiguchi, Keiko Kataoka

Research output: Contribution to journalArticlepeer-review

16 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Switching from aflibercept to brolucizumab for the treatment of refractory neovascular age-related macular degeneration'. Together they form a unique fingerprint.

Medicine & Life Sciences